BRIEF-Acasti Pharma Q2 loss per share $0.22
Oct 11 (Reuters) - Acasti Pharma Inc
* reports second quarter 2017 financial results
* Qtrly loss per share $0.22
* if co does not raise additional funds, there exists uncertainty that casts substantial doubt about ability to continue as going concern
* Management has reasonable expectation that corporation will be able to raise additional funds Source text for Eikon: Further company coverage:
© Thomson Reuters 2016 All rights reserved.